Taylor Madyson, Griffin Russell L, Walker Jeremey, James Catina, Akinsanya Angela, Duncan Mary, Lee Rachael A
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL USA.
Antimicrob Steward Healthc Epidemiol. 2025 Feb 12;5(1):e41. doi: 10.1017/ash.2025.9. eCollection 2025.
We aimed to determine if implementation of universal nasal decolonization with daily chlorhexidine bathing will decrease blood stream infections (BSI) in patients undergoing extracorporeal membrane oxygenation (ECMO).
Retrospective cohort study.
Tertiary care facility.
Patients placed on ECMO from January 1, 2017 to December 31, 2023.
Daily bathing with 4% chlorhexidine soap and universal mupirocin nasal decolonization were initiated for all ECMO patients May 2021. The primary outcome was rate of ECMO-attributable positive blood cultures. Zero-inflated Poisson regression analysis was performed to estimate rate ratios (RRs) for the association between decolonization with BSI rates.
A total of 776 patients met inclusion criteria during the study period, 425 (55%) preimplementation and 351 (45%) post-implementation. Following implementation of decolonization, the overall incidence rate of BSI increased nonsignificantly from 10.7 to 14.0 infections per 1000 ECMO days (aRR 1.09, 95% CI 0.74-1.59). For gram-positive cocci (GPC) pathogens, a nonsignificant 40% increased rate was observed in the post-implementation period (RR 1.40, 95% CI 0.89-2.21), due mostly to a significant increase in the crude rate of BSI (RR 1.89, 95% CI 1.01-3.55). Excluding resulted in a nonsignificant 28% decreased rate (aRR 0.72, 95% CI 0.39-1.36) due to a nonsignificant 55% decreased rate of MRSA (aRR 0.45, 95% CI 0.18-3.58).
Implementation of a universal decolonization protocol did not significantly reduce rates of certain BSIs, including MRSA and other gram-positive pathogens. Although nonsignificant, reduction in BSI rates in this patient population has important implications on surveillance metrics, such as MRSA, and in the future, hospital-onset bacteremia.
我们旨在确定每日使用洗必泰沐浴进行普遍鼻腔去定植是否会降低接受体外膜肺氧合(ECMO)治疗的患者的血流感染(BSI)发生率。
回顾性队列研究。
三级医疗机构。
2017年1月1日至2023年12月31日期间接受ECMO治疗的患者。
2021年5月起,对所有接受ECMO治疗的患者开始每日使用4%洗必泰肥皂沐浴并进行普遍的莫匹罗星鼻腔去定植。主要结局是ECMO相关的血培养阳性率。采用零膨胀泊松回归分析来估计去定植与BSI发生率之间关联的率比(RRs)。
研究期间共有776例患者符合纳入标准,425例(55%)在实施前,351例(45%)在实施后。去定植实施后,BSI的总体发病率从每1000个ECMO日10.7例感染无显著增加至14.0例感染(调整后RR 1.09,95%可信区间0.74 - 1.59)。对于革兰氏阳性球菌(GPC)病原体,实施后观察到发病率无显著增加40%(RR 1.40,95%可信区间0.89 - 2.21),主要是由于BSI的粗发病率显著增加(RR 1.89,95%可信区间1.01 - 3.55)。排除……后,由于耐甲氧西林金黄色葡萄球菌(MRSA)发病率无显著降低55%(调整后RR 0.45,95%可信区间0.18 - 3.58),导致发病率无显著降低28%(调整后RR 0.72,95%可信区间0.39 - 1.36)。
实施普遍去定植方案并未显著降低包括MRSA和其他革兰氏阳性病原体在内的某些BSI的发生率。尽管无显著差异,但该患者群体中BSI发生率的降低对监测指标(如MRSA)以及未来医院获得性菌血症具有重要意义。